Anti-IL-17 & TNF-alpha Reference Antibody (COVA322)
Product Sizes
100 ug
£495.00
CHBA043-100UG
1 mg
£1135.00
CHBA043-1MG
About this Product
- SKU:
- CHBA043
- Additional Names:
- COVA322
- Application:
- Cell-based/Functional Assay, Detection/Quantitation, ELISA, FACS, Flow Cytometry
- Buffer:
- 25mM histidine, 8% sucrose, 0.01% Tween80 pH6.2
- Clonality:
- Recombinant Monoclonal
- Concentration:
- 1 mg/ml
- Extra Details:
- Lulizumab is a monovalent Anti-Human CD28 Domain Antibody Antagonist designed for the treatment of autoimmune diseases.
- Formulation:
- 25mM histidine, 8% sucrose, 0.01% Tween80 pH6.2
- Immunogen:
- TNFSF2 / TNFa,IL-17 / IL-17A / CTLA-8
- Isotype:
- IgG
- Molecular Weight:
- 161.9 kDa
- Purity:
- >95%
- Purification:
- Protein A Purified
- Shipping Conditions:
- Blue Ice
- Storage Conditions:
- -70[o]C Aliquot. Avoid freeze/thaw cycles., -20[o]C Aliquot. Avoid freeze/thaw cycles., 2-8[o]C Aliquot. Avoid freeze/thaw cycles.
- Supplier:
- Sanyou Biopharmaceuticals
- Type:
- Antibody: Recombinant Antibodies
- Manufacturer's Data Sheet:CHBA043
